• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病患者胰腺外分泌功能不全的患病率较低。

Low prevalence of exocrine pancreatic insufficiency in patients with diabetes mellitus.

机构信息

Department of Internal Medicine, Slovenj Gradec General Hospital, Gosposvetska 1, 2380 Slovenj Gradec, Slovenia.

出版信息

Pancreatology. 2013 Jul-Aug;13(4):343-6. doi: 10.1016/j.pan.2013.05.010. Epub 2013 Jun 14.

DOI:10.1016/j.pan.2013.05.010
PMID:23890131
Abstract

INTRODUCTION

Exocrine pancreatic insufficiency (EPI) can occur in patients with diabetes mellitus (DM). Incidence of EPI and its clinical significance remain poorly defined. The aim of our study was to determine whether exocrine pancreatic function is impaired in patients with DM.

PATIENTS AND METHODS

One hundred and fifty consecutive patients, mean age 59.0 (± 12.0 years), with DM lasting at least 5 years were included in the study. We included 50 patients with type 1 DM (DM1), 50 insulin-treated patients DM type 2 (DM2-insulin) and 50 non-insulin treated patients with DM type 2 (DM2 no-insulin). Diagnosis of DM was established from health records, lasting 15.0 ± 9.9 years on average. EPI was diagnosed with a fecal elastase-1 concentration (FE1) of less than 200 μg/g (ELISA).

RESULTS

FE1 was reduced in 8 (5.4%) patients: mildly reduced (100-200 μg/g) in 4 patients (2.7%) and markedly reduced (<100 μg/g) in 4 patients (2.7%). Frequency of EPI was 3 in DM1, 5 in DM2(insulin) and none in DM2 (no-insulin) groups.

CONCLUSIONS

EPI in DM occurred less frequently than in previous studies, probably due to our strict exclusion criteria (age, alcohol intake).

摘要

简介

外分泌胰腺功能不全(EPI)可发生于糖尿病(DM)患者中。EPI 的发生率及其临床意义仍未明确。本研究旨在确定 DM 患者的外分泌胰腺功能是否受损。

患者与方法

本研究纳入了 150 例连续患者,平均年龄 59.0(±12.0 岁),DM 病史至少 5 年。我们纳入了 50 例 1 型糖尿病(DM1)患者、50 例接受胰岛素治疗的 2 型糖尿病(DM2-胰岛素)患者和 50 例未接受胰岛素治疗的 2 型糖尿病(DM2-无胰岛素)患者。DM 的诊断依据病史,平均病程为 15.0±9.9 年。EPI 通过粪便弹性蛋白酶-1 浓度(FE1)<200μg/g(ELISA)进行诊断。

结果

8 例(5.4%)患者的 FE1 降低:4 例(2.7%)轻度降低(100-200μg/g),4 例(2.7%)显著降低(<100μg/g)。EPI 在 DM1 中的发生率为 3 例,DM2-胰岛素为 5 例,DM2-无胰岛素组无 1 例。

结论

与既往研究相比,DM 中的 EPI 发生率较低,可能是由于我们严格的排除标准(年龄、饮酒)所致。

相似文献

1
Low prevalence of exocrine pancreatic insufficiency in patients with diabetes mellitus.糖尿病患者胰腺外分泌功能不全的患病率较低。
Pancreatology. 2013 Jul-Aug;13(4):343-6. doi: 10.1016/j.pan.2013.05.010. Epub 2013 Jun 14.
2
Screening for pancreatic exocrine insufficiency in patients with diabetes mellitus.糖尿病患者胰腺外分泌功能不全的筛查
Am J Gastroenterol. 2003 Dec;98(12):2672-5. doi: 10.1111/j.1572-0241.2003.08730.x.
3
MRI and MRCP findings of the pancreas in patients with diabetes mellitus: compared analysis with pancreatic exocrine function determined by fecal elastase 1.糖尿病患者胰腺的MRI和MRCP表现:与通过粪便弹性蛋白酶1测定的胰腺外分泌功能的对比分析
J Clin Gastroenterol. 2009 Feb;43(2):165-70. doi: 10.1097/MCG.0b013e3181587912.
4
High prevalence of exocrine pancreatic insufficiency in diabetes mellitus. A multicenter study screening fecal elastase 1 concentrations in 1,021 diabetic patients.糖尿病中外分泌性胰腺功能不全的高患病率。一项在1021名糖尿病患者中筛查粪便弹性蛋白酶1浓度的多中心研究。
Pancreatology. 2003;3(5):395-402. doi: 10.1159/000073655. Epub 2003 Sep 24.
5
Pancreatic exocrine function in patients with diabetes.糖尿病患者的胰腺外分泌功能。
Diabet Med. 2012 Aug;29(8):1047-54. doi: 10.1111/j.1464-5491.2012.03597.x.
6
Pancreatic exocrine insufficiency in diabetes mellitus - prevalence and characteristics.糖尿病患者胰腺外分泌功能不全的患病率和特征。
Eur J Intern Med. 2019 Oct;68:18-22. doi: 10.1016/j.ejim.2019.07.021. Epub 2019 Aug 8.
7
Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus.低粪便弹性蛋白酶1水平并不表明1型糖尿病患者存在外分泌性胰腺功能不全。
Pancreas. 2008 Apr;36(3):274-8. doi: 10.1097/MPA.0b013e3181656f8.
8
Screening for undiagnosed pancreatic exocrine insufficiency (PEI) in a cohort of diabetic patients using faecal elastase testing and PEI scoring system.使用粪便弹性蛋白酶检测和 PEI 评分系统对一组糖尿病患者进行未诊断的胰腺外分泌功能不全(PEI)筛查。
Acta Diabetol. 2024 Oct;61(10):1301-1307. doi: 10.1007/s00592-024-02307-z. Epub 2024 May 26.
9
Prevalence and determinants of exocrine pancreatic insufficiency among older adults: results of a population-based study.老年人外分泌性胰腺功能不全的患病率及影响因素:一项基于人群研究的结果
Scand J Gastroenterol. 2005 Jun;40(6):697-704. doi: 10.1080/00365520510023116.
10
[Pancreatic exocrine function in diabetes mellitus. Determination of fecal elastase].[糖尿病患者的胰腺外分泌功能。粪便弹性蛋白酶的测定]
Rev Med Chil. 2006 Apr;134(4):407-14. doi: 10.4067/s0034-98872006000400001. Epub 2006 May 25.

引用本文的文献

1
European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence-based recommendations.欧洲胰腺外分泌功能不全诊断与治疗指南:UEG、EPC、EDS、ESPEN、ESPGHAN、ESDO和ESPCG基于证据的建议。
United European Gastroenterol J. 2025 Feb;13(1):125-172. doi: 10.1002/ueg2.12674. Epub 2024 Dec 5.
2
Screening for undiagnosed pancreatic exocrine insufficiency (PEI) in a cohort of diabetic patients using faecal elastase testing and PEI scoring system.使用粪便弹性蛋白酶检测和 PEI 评分系统对一组糖尿病患者进行未诊断的胰腺外分泌功能不全(PEI)筛查。
Acta Diabetol. 2024 Oct;61(10):1301-1307. doi: 10.1007/s00592-024-02307-z. Epub 2024 May 26.
3
Symptoms, burden, and unmet needs of patients living with exocrine pancreatic insufficiency: a narrative review of the patient experience.
胰腺外分泌功能不全患者的症状、负担和未满足的需求:对患者体验的叙述性综述。
BMC Gastroenterol. 2024 Mar 14;24(1):101. doi: 10.1186/s12876-024-03188-w.
4
United Kingdom Early Detection Initiative (UK-EDI): protocol for establishing a national multicentre cohort of individuals with new-onset diabetes for early detection of pancreatic cancer.英国早期检测倡议(UK-EDI):建立一个新诊断糖尿病患者的全国多中心队列以早期发现胰腺癌的方案。
BMJ Open. 2022 Oct 10;12(10):e068010. doi: 10.1136/bmjopen-2022-068010.
5
The Prevalence and Characteristics of Exocrine Pancreatic Insufficiency in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.2型糖尿病患者外分泌性胰腺功能不全的患病率及特征:一项系统评价和荟萃分析
Int J Endocrinol. 2022 Jul 19;2022:7764963. doi: 10.1155/2022/7764963. eCollection 2022.
6
Relationship between Pancreas Exocrine Insufficiency and Cardiac Autonomic Neuropathy in Patients with Type 2 Diabetes Mellitus.2 型糖尿病患者胰腺外分泌功能不全与心脏自主神经病变的关系。
Turk J Gastroenterol. 2021 May;32(5):481-487. doi: 10.5152/tjg.2021.19373.
7
Exocrine Pancreatic Insufficiency in Type 1 and Type 2 Diabetes.1型和2型糖尿病中的外分泌性胰腺功能不全
Curr Diab Rep. 2020 Apr 1;20(6):18. doi: 10.1007/s11892-020-01304-0.
8
Structure and function of the exocrine pancreas in patients with type 1 diabetes.1 型糖尿病患者胰腺外分泌的结构和功能。
Rev Endocr Metab Disord. 2019 Jun;20(2):129-149. doi: 10.1007/s11154-019-09501-3.
9
Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer.继发于慢性胰腺炎和胰腺癌的 3c 型(胰源性)糖尿病。
Lancet Gastroenterol Hepatol. 2016 Nov;1(3):226-237. doi: 10.1016/S2468-1253(16)30106-6. Epub 2016 Oct 12.
10
Association of faecal elastase 1 with non-fasting triglycerides in type 2 diabetes.2型糖尿病患者粪便弹性蛋白酶1与非空腹甘油三酯的相关性
Pancreatology. 2016 Jul-Aug;16(4):563-9. doi: 10.1016/j.pan.2016.03.015. Epub 2016 Mar 30.